A 2026 Spanish Rett Syndrome Behavior Questionnaire validation preprint found strong test-retest reliability across 51 caregivers, including an intraclass correlation coefficient of 0.907 and a 31-person short-interval subset with Pearson r2 = 0.8663.1 The result supports Spanish-language research access, but it is linguistic validation rather than proof that the scale diagnoses Rett syndrome or measures …
A self-localized ultrafast pencil beam is not a brain treatment, but it could become useful imaging infrastructure for neuroscience and drug-delivery research. In an arXiv preprint, Cao et al. generated a stable ultrafast beam inside a standard multimode fiber and used it for volumetric multiphoton imaging of intact mouse enteric nervous tissue and a live …
A 2026 mouse study found that long-term CoQ10 exposure reduced working-memory errors in Purkinje-cell-specific Drp1-deficient mice, tying the behavioral rescue to Coa6 binding and support for mitochondrial respiratory-chain function.1 The result supports a narrow mechanistic CoQ10-Coa6 pathway under neuronal mitochondrial dysfunction while leaving human memory-supplement claims untested. Research Highlights Working memory improved in a mouse …
A 2026 Molecular Psychiatry analysis from the Rhineland Study found that blood-derived microRNA signatures were associated with hippocampal brain structure: 6 microRNAs linked cross-sectionally to left hippocampal volume, and 5 different microRNAs linked longitudinally to hippocampal atrophy rates.1 The result is biomarker-discovery evidence for brain aging, not a ready dementia blood test. Research Highlights Baseline …
A 2025 Science Advances mouse study found a more brain-dependent metformin mechanism than the usual liver-gut framing suggests: low-dose metformin lost its glucose-lowering effect when brain Rap1 signaling could not be reduced, and 36 of 47 ventromedial-hypothalamus SF1 neurons responded directly to metformin.1 Research Highlights Low-dose metformin needed brain Rap1: Control mice lowered glucose after …
A 2026 longitudinal study found reassuring cognitive trajectories after mild-to-moderate COVID-19: Alpha/Delta and Omicron groups both improved by follow-up, and neither group showed persistent neuropsychological test deficits vs. population norms. Psychiatric symptoms and fatigue were also broadly similar across variants.1 Research Highlights 55 adults were assessed: 27 were infected during the Alpha/Delta era and 28 …
A 2026 behavioral-variant frontotemporal dementia MRI study found that simple visual ratings of orbitofrontal and frontoinsular brain atrophy helped separate probable from possible bvFTD, with baseline left orbitofrontal atrophy predicting 3.77-fold higher odds of probable bvFTD classification.1 Research Highlights 143 people were rated: the study included 93 probable bvFTD cases, 15 possible bvFTD cases, and …